Integer Holdings Corporation (NYSE:ITGR – Get Free Report) insider Kirk Thor sold 11,767 shares of Integer stock in a transaction dated Tuesday, September 15th. The shares were sold at an average price of $126.23, for a total value of $1,485,348.41. Following the completion of the transaction, the insider owned 7,153 shares in the company, valued at approximately $902,923.19. This represents a 62.19% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website.
Integer Price Performance
Shares of ITGR stock traded up $0.01 on Wednesday, reaching $126.22. The company had a trading volume of 1,124,095 shares, compared to its average volume of 707,592. The business’s 50-day moving average is $116.25 and its 200 day moving average is $98.19. Integer Holdings Corporation has a one year low of $62.00 and a one year high of $126.79. The company has a quick ratio of 2.41, a current ratio of 3.73 and a debt-to-equity ratio of 0.75. The stock has a market capitalization of $4.29 billion, a PE ratio of 34.49, a price-to-earnings-growth ratio of 2.40 and a beta of 0.62.
Integer (NYSE:ITGR – Get Free Report) last announced its quarterly earnings results on Monday, August 3rd. The medical equipment provider reported $1.60 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.38 by $0.22. The company had revenue of $464.11 million for the quarter, compared to analyst estimates of $451.07 million. Integer had a net margin of 6.97% and a return on equity of 12.79%. The firm’s revenue was down 2.6% on a year-over-year basis. During the same period in the previous year, the firm posted $1.55 EPS. Equities research analysts forecast that Integer Holdings Corporation will post 6.09 EPS for the current fiscal year.
Hedge Funds Weigh In On Integer
Analyst Ratings Changes
Several brokerages have recently issued reports on ITGR. Freedom Capital downgraded shares of Integer from a “strong-buy” rating to a “hold” rating in a report on Tuesday, August 4th. Piper Sandler downgraded Integer from an “overweight” rating to a “hold” rating and set a $127.00 price objective on the stock. in a report on Monday, August 3rd. Citigroup boosted their price objective on Integer from $92.00 to $96.00 and gave the stock a “neutral” rating in a research report on Wednesday, July 8th. KeyCorp cut Integer from an “overweight” rating to a “sector weight” rating in a report on Monday, August 3rd. Finally, Wells Fargo & Company lifted their price target on Integer from $84.00 to $127.00 and gave the company an “equal weight” rating in a research note on Tuesday, August 4th. One analyst has rated the stock with a Buy rating and thirteen have issued a Hold rating to the company. According to MarketBeat.com, the stock presently has an average rating of “Hold” and an average price target of $109.86.
Check Out Our Latest Analysis on ITGR
Integer Company Profile
Integer Holdings Corporation, doing business as Integer, is a medical device contract development and manufacturing company. The company partners with medical technology companies to design, develop and manufacture components and finished products used in a range of healthcare applications.
Integer’s medical products include batteries and power sources, implantable components, electrodes, leads, catheters and other products used in cardiovascular, neuromodulation, vascular, orthopedic, diabetes and minimally invasive medical devices.
Further Reading
- Five stocks we like better than Integer
- 3 Luxury Consumer Brands to Watch in a Beaten-Down Sector
- Jackson’s Record Quarter Powers the Bull Case
- Holiday Shopping Is Almost Here—And Target May Be Ready to Win Big
- AI Panic Hit Tech Stocks—But NVIDIA’s Growth Engine Is Intact
Receive News & Ratings for Integer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Integer and related companies with MarketBeat.com's FREE daily email newsletter.
